Firefly Current Deferred Revenue from 2010 to 2026
| AIFF Stock | 1.12 0.05 4.67% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 11.7 K | Current Value 11.1 K | Quarterly Volatility 408.1 K |
Check Firefly Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Firefly Neuroscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 104.4 K, Total Revenue of 92.3 K or Gross Profit of 35.1 K, as well as many indicators such as Price To Sales Ratio of 176, Dividend Yield of 0.0 or Days Sales Outstanding of 195. Firefly financial statements analysis is a perfect complement when working with Firefly Neuroscience Valuation or Volatility modules.
Firefly | Current Deferred Revenue | Build AI portfolio with Firefly Stock |
Latest Firefly Neuroscience's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Firefly Neuroscience over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Firefly Neuroscience's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Firefly Neuroscience's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Firefly Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 696,032 | |
| Geometric Mean | 324,983 | |
| Coefficient Of Variation | 58.63 | |
| Mean Deviation | 349,687 | |
| Median | 946,884 | |
| Standard Deviation | 408,061 | |
| Sample Variance | 166.5B | |
| Range | 935.8K | |
| R-Value | (0.79) | |
| Mean Square Error | 67.8B | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | (63,530) | |
| Total Sum of Squares | 2.7T |
Firefly Current Deferred Revenue History
About Firefly Neuroscience Financial Statements
Firefly Neuroscience stakeholders use historical fundamental indicators, such as Firefly Neuroscience's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Firefly Neuroscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Firefly Neuroscience's assets and liabilities are reflected in the revenues and expenses on Firefly Neuroscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Firefly Neuroscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 11.7 K | 11.1 K |
Currently Active Assets on Macroaxis
When determining whether Firefly Neuroscience is a strong investment it is important to analyze Firefly Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Firefly Neuroscience's future performance. For an informed investment choice regarding Firefly Stock, refer to the following important reports:Check out the analysis of Firefly Neuroscience Correlation against competitors. For more detail on how to invest in Firefly Stock please use our How to Invest in Firefly Neuroscience guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Firefly Neuroscience. If investors know Firefly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Firefly Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.26) | Revenue Per Share | Quarterly Revenue Growth 10.758 | Return On Assets | Return On Equity |
The market value of Firefly Neuroscience is measured differently than its book value, which is the value of Firefly that is recorded on the company's balance sheet. Investors also form their own opinion of Firefly Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Firefly Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Firefly Neuroscience's market value can be influenced by many factors that don't directly affect Firefly Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Firefly Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Firefly Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Firefly Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.